Chromogranin A deficiency attenuates tauopathy by altering epinephrine–alpha-adrenergic receptor signaling in PS19 mice
Open Access
- 20 May 2025
- journal article
- research article
- Published by Springer Nature in Nature Communications
- Vol. 16 (1) , 1-18
Abstract
Metabolic disorders such as insulin resistance and hypertension are potential risk factors for aging and neurodegenerative diseases. These conditions are reversed in Chromogranin A (CgA) knockout (CgA-KO) mice. CgA is known to be associated with protein aggregates in the brains of neurodegenerative diseases including Alzheimer’s disease (AD). Here, we investigated the role of CgA in Tau pathogenesis in AD and corticobasal degeneration (CBD). CgA ablation in Tauopathy mice (PS19) (CgA-KO/PS19) reduced pathological Tau aggregation and spreading, extended lifespan, and improved cognitive function. Transcriptomic and metabolite analysis of mouse cortices revealed elevated alpha-1-adrenergic receptors (Adra1) expression and high Epinephrine (EPI) levels in PS19 mice compared to WT mice, mirroring observations in AD and CBD patients. CgA depletion in PS19 mice lowered cortical EPI levels and the expression of Adra1 back to normal. Treatment of WT hippocampal organotypic slice cultures with EPI or Adra1 agonist promoted, while an Adra1 antagonist inhibited Tau hyperphosphorylation and formation of neurofibrillary tangles, which is unaltered upon CgA depletion. These findings demonstrate the involvement of CgA in Tau pathogenesis and highlight the interplay between the EPI-Adra1 signaling pathway and CgA in Tauopathy.Keywords
All Related Versions
Funding Information
- Association for Frontotemporal Degeneration (2022-0002)
This publication has 80 references indexed in Scilit:
- Degenerative changes in epinephrine tonic vasomotor neurons in Alzheimer's diseaseBrain Research, 1994
- The chromogranins A and B: The first 25 years and future perspectivesNeuroscience, 1992
- Chromogranin A-like immunoreactive neurites are major constituents of senile plaques.1991
- Synaptophysin and chromogranin A immunoreactivities in senile plaques of Alzheimer's diseaseBrain Research, 1991
- Evidence for Decreased Transport of PNMT Protein in Advanced Alzheimer's DiseaseJournal of the American Geriatrics Society, 1990
- A high ratio of chromogranin A to synaptin/synaptophysin is a common feature of brains in Alzheimer and Pick diseaseFEBS Letters, 1990
- An increased pool of secretory hormones and peptides in adrenal medulla of stroke-prone spontaneously hypertensive rats.Hypertension, 1989
- Pancreastatin, a novel pancreatic peptide that inhibits insulin secretionNature, 1986
- Enzymatic Synthesis of Adrenaline in Mammalian BrainNature, 1969
- Secretion of a Chromaffin Granule Protein, Chromogranin, from the Adrenal Gland after Splanchnic StimulationNature, 1967